超300亿美元!默沙东拟收购一家Biotech

CHC医疗传媒
Jan 12

1月8日,据《金融时报》报道:默沙东正在与Revolution Medicines讨论收购事宜,价格范围为280亿美元~320亿美元。报告发布后,Revolution的股价在盘后交易中上涨了近16%。然而就在两天前谣传艾伯维要以200亿美元收购Revolution Medicines,后者股价也暴涨28.63%,后艾伯维予以否认。知情人士称,默沙东一直在寻求收购Revolution,但交易尚未敲定...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10